Abbott Northwestern Hospital

Abbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart Valve

Retrieved on: 
星期二, 四月 2, 2024
Disease, Atrial fibrillation, Risk, Anatomy, Patient, Aortic stenosis, Endoclip, Tricuspid regurgitation, Structural heart disease, Death, Tricuspid valve, Abbott Northwestern Hospital, Quality of life, Heart failure, Leg, Heart, MitraClip, Safety, Fatigue, Blood, FDA, Physician, Food, Pharmaceutical industry

The tricuspid valve controls blood as it flows from the heart's right atrium to the right ventricle.

Key Points: 
  • The tricuspid valve controls blood as it flows from the heart's right atrium to the right ventricle.
  • TR occurs when the valve doesn't close properly, causing a leak and allowing blood to flow backward in the heart.
  • TR can force the heart to work harder, causing debilitating symptoms such as fatigue and shortness of breath.
  • TriClip has been approved for use in more than 50 countries, including in Europe and Canada, since its initial CE Mark approval in 2020.

Halunen Law Wins $4.6 Million Verdict On Behalf of Client in Whistleblower Case

Retrieved on: 
星期二, 一月 23, 2024
CRL, Minneapolis–Saint Paul, Defendant, Abbott Northwestern Hospital, Safety, Light, Property management

MINNEAPOLIS, Jan. 23, 2024 /PRNewswire/ -- A board-certified radiologist, senior shareholder, and employee of Consulting Radiologist Limited (CRL) was awarded $4.6 million in damages by a Hennepin County jury for being wrongfully terminated under Minnesota's whistleblower protection law. Halunen Law of Minneapolis, Minnesota, represented the plaintiff in this landmark trial. CRL contracts to provide services to Allina Health, including Abbott Northwestern, in the Twin Cities metro area. 

Key Points: 
  • Halunen Law of Minneapolis, Minnesota, represented the plaintiff in this landmark trial.
  • CRL contracts to provide services to Allina Health, including Abbott Northwestern, in the Twin Cities metro area.
  • The two-week-long trial and deliberation resulted in a jury verdict, finding the plaintiff was terminated in violation of the Minnesota Whistleblower Act .
  • Attorney Pamela Johnson, one of Halunen Law's senior trial attorneys representing the plaintiff, commented: "Today we sent a message.

Memorial Neuroscience Institute Performs Livestreamed Brain Aneurysm Procedure

Retrieved on: 
星期二, 十一月 14, 2023
Aneurysm, Human, DRS, Neck, Brain, Safety, Developed country, Memorial Regional Hospital (Florida), Mischer Neuroscience Institute, WEB, Spine, Mehta, Multimedia, Probability, Journal of NeuroInterventional Surgery, Subarachnoid hemorrhage, Memorial Hermann Health System, Abbott Northwestern Hospital, Neurology, Stroke, Neoplasm, Rehabilitation, Multiple sclerosis, Epilepsy, Neuroradiology, Family, Physician, Quality of life, Society, Medical imaging

HOLLYWOOD, Fla., Nov. 14, 2023 /PRNewswire-PRWeb/ -- Nearly 1,800 miles separated Dr. Brijesh Mehta and Dr. Josser Delgado during a recent procedure to treat a complex brain aneurysm, but that didn't mean the renowned neurologists weren't collaborating in real time.

Key Points: 
  • Dr. Brijesh Mehta performed what is believed to be the first live-streamed endovascular neurosurgery to fully secure a complex brain aneurysm using the novel Microvention Woven EndoBridge (WEB) device.
  • - Dr. Brijesh Mehta, Memorial Neuroscience Institute
    Dr. Mehta, a vascular interventional neurologist and medical director of the Comprehensive Stroke and Neurointerventional Surgery programs at the Memorial Neuroscience Institute, performed the first live-streamed endovascular neurosurgery to fully secure a complex brain aneurysm using the novel Microvention Woven EndoBridge (WEB) device.
  • The catheter-based image navigation procedure enabled the placement of the WEB device to secure the aneurysm.
  • Memorial Neuroscience Institute offers advanced diagnoses, comprehensive treatment, compassionate care, and rehabilitation for complex neurological conditions.

New Data Show Superiority of Abbott's TriClip™ Device Compared to Medical Therapy for Tricuspid Regurgitation

Retrieved on: 
星期六, 三月 4, 2023
Bright, Risk, Heart failure, Abbott Northwestern Hospital, Mitral regurgitation, Self-assessment, Structural heart disease, Endoclip, Pivotal, American College of Cardiology, The New England Journal of Medicine, Patient, Tricuspid valve, American College, ACC, KCCQ, Love, Mortality, Quality of life, NYSE, Endocarditis, Safety, Medical imaging, Pharmaceutical industry, Medical device

The TRILUMINATE™ Pivotal study evaluates the superiority of TriClip compared to medical therapy in treating patients with severe, symptomatic tricuspid regurgitation (TR) who are at intermediate or greater risk for open-heart surgery.

Key Points: 
  • The TRILUMINATE™ Pivotal study evaluates the superiority of TriClip compared to medical therapy in treating patients with severe, symptomatic tricuspid regurgitation (TR) who are at intermediate or greater risk for open-heart surgery.
  • Mortality or tricuspid valve surgery and heart failure hospitalizations did not appear different between the groups at one year.
  • At 30 days, only 1.7% of patients who received the device experienced major adverse events, with no urgent surgery or endocarditis.
  • Abbott will also be presenting at ACC late-breaking five-year results from its landmark COAPT™ trial of the MitraClip™ TEER device for functional mitral regurgitation in heart failure.

Allina Health and Owens & Minor Expand Partnership and Announce New Strategic Collaboration

Retrieved on: 
星期二, 八月 9, 2022
Health, Transport, Logistics, Supply Chain Management, Manufacturing, General Health, Other Manufacturing, Supply chain, Multimedia, NYSE, Hospital, Owens & Minor, Communication, Health, Patient, Personal protective equipment, Allina Health, EVP, Twitter, Partnership, OMI, Industry, Abbott Northwestern Hospital, PPE, Physician, Heart, Solution, LinkedIn, Pharmacy, Efficiency, Warehouse, Management

View the full release here: https://www.businesswire.com/news/home/20220809005800/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220809005800/en/
    Abbott Northwestern Hospital, part of Allina Health (Photo: Business Wire)
    The integrated service model is an evolution of the 20-year partnership between Allina Health and Owens & Minor.
  • Allina Health believes that deepening our successful relationship with Owens & Minor will elevate our ability to ensure that our providers and clinical staff have the products they need, when they need them, said Thomas M. Lubotsky, Vice President of Supply Chain, Allina Health.
  • We are excited by what this new phase of our 20-year strategic partnership with Owens & Minor will bring.
  • Allina Health is dedicated to the prevention and treatment of illness and enhancing the greater health of individuals, families and communities throughout Minnesota and western Wisconsin.

Recent Study Demonstrates Leveraging ECV-CTA Assessment from Routine TAVR Evaluation Correlates Well with ECV-CMR and Has Significant Methodological Implications

Retrieved on: 
星期二, 七月 19, 2022
Cardiac amyloidosis, Acquisition, Congress, Abraxis BioScience, Structure, Weeping Angel, Patient, Coronary, Solution, CCTA, Aortic stenosis, Coronary CT angiography, Technology, Pulmonary fibrosis, Deep learning, Ownership, Workflow, Map, ImmunityBio, CMR, Marketing, ECV, Society, Aortic valve, Efficiency, Risk, TAVR, SCCT, The San Diego Union-Tribune, CT, Abbott Northwestern Hospital, Population, Medical imaging, NantWorks, MD

NEWARK, Calif., July 19, 2022 /PRNewswire-PRWeb/ -- A study abstract published at the annual Society of Cardiac Computed Tomography (SCCT) congress last week indicated an excellent correlation of extracellular volume fraction (ECV) computed tomography (CT) with ECV cardiac magnetic resonance (CMR) in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR) and had significant methodological implications. The pilot research study from Allina Health Minneapolis Heart Institute at Abbott Northwestern Hospital utilized a commonly available prospective ECG-gated acquisition, which provided reliable imaging quality for ECV-CT analysis using Ziosoft, one of the only commercially available ECV-CT solutions.

Key Points: 
  • This technology helped enable ECV-CT assessment making it a viable, non-invasive approach for non-invasive assessment of myocardial fibrosis and potential pre-screening of Cardiac Amyloidosis during a pre-planning TAVR or post-TAVR procedure."
  • CT TAVR planning also can evaluate ECV to indicate the presence of concomitant cardiac amyloidosis, which can be as frequent as 12-15% in this elderly population.
  • "With the U.S. performing more than 73,000 TAVR procedures annually, the findings of this study could be significant," said Rajeev Taitriya, vice president of marketing and business development for Ziosoft.
  • We are pleased to be a part of this and many other studies showing the power of Ziosoft technology."

Luis A. Pagan-Carlo, MD, FACC, is recognized by Continental Who's Who

Retrieved on: 
星期三, 二月 9, 2022
Biological engineering, TEE, American Medical Association, Temple University School of Medicine, Delnor-Wiggins Pass State Park, Medicine, Boston Medical Center, Electricity, American Board of Internal Medicine, American College, Technology, Patient, University, American Heart Association, Indian Medical Association, American Board of Commissioners for Foreign Missions, Continental, Biomedical engineering, Boston University, Founder, TTE, City, Minnesota Opera, Pennsylvania State University, Echocardiography, Health, Abbott Northwestern Hospital, Biomedicine, Physician, FACC, American College of Cardiology, ABIM, Internal medicine, Medical imaging, Medical device, Cardiology, MD

Luis A. Pagan-Carlo has been in medical practice for over three decades as a board-certified Cardiologist, and currently works as the Founder of Avyscoer.

Key Points: 
  • Luis A. Pagan-Carlo has been in medical practice for over three decades as a board-certified Cardiologist, and currently works as the Founder of Avyscoer.
  • He first began his Medical studies by attended Boston University, earning a Bachelor of Science degree in Electrical Engineering in 1985.
  • Dr. Pagan-Carlo then took courses at Penn State University, graduating with his Master of Science degree in Bioengineering and Biomedical Engineering in 1990.
  • In his spare time, Dr. Pagan-Carlo is a board member of the Minnesota Opera and Theatre Latte Da.

Research Reveals Improved Outcomes and Decreased Mortality in Management of Aortic Dissections with Care Plans Designed by Multidisciplinary Expertise

Retrieved on: 
星期四, 十一月 18, 2021
Patient, Research, Heart, Caregiver, Abbott Northwestern Hospital, Technology, AAD, Death, Vein, Diagnosis, Awareness, MD, Level 1, Health, Blood vessel, Education, Aorta, Manuscript, Innovation, Survival, GLOBE, Artery, Mortality, Journal, Standard of care, Medicine, Dentistry

Minneapolis, Minn., Nov. 18, 2021 (GLOBE NEWSWIRE) -- The Minneapolis Heart Institute Foundation(MHIF) announced the publication of research showing improved patient outcomes and significantly decreased 30-day mortality in aortic dissection patients managed through a unique comprehensive care strategy designed by a team with multidisciplinary expertise.

Key Points: 
  • Minneapolis, Minn., Nov. 18, 2021 (GLOBE NEWSWIRE) -- The Minneapolis Heart Institute Foundation(MHIF) announced the publication of research showing improved patient outcomes and significantly decreased 30-day mortality in aortic dissection patients managed through a unique comprehensive care strategy designed by a team with multidisciplinary expertise.
  • The manuscript, Impact of a multidisciplinary acute aortic dissection program: Improved outcomes with a comprehensive initial surgical repair strategy, was published in the Journal of Vascular Surgery .
  • Scientific Innovation and Research MHIF is a recognized leader across all specialties of heart and vascular research.
  • MHIF research has improved the standard of care around the world through protocols like Level One for heart attack, which significantly improved outcomes and survival for patients.